Xalles Holdings Inc. (“Xalles”) (OTC: XALL), a leading holding company, specializing in technology and financial services, announces its planned acquisition of RPM-One, a renowned data analytics and technology firm. This move signifies a strategic expansion into the digital healthcare market, with RPM-One’s flagship product, EZ Digital, poised to enhance Xalles’ portfolio.
RPM-One, Inc. specializes in a Unified Telemetry Platform that offers broad industry applicability by reducing data latency and storage costs and features customizable AI-driven automation and decision support. EZ Digital, its primary offering, is transforming preventive healthcare for large risk-bearing entities through a unique direct pay membership model. The acquisition by Xalles is set to boost RPM-One’s operational efficiency, affordability, and market reach.
Thomas Nash, CEO of Xalles Holdings, expressed enthusiasm about the acquisition, “the addition of RPM-One, particularly EZ Digital’s sophisticated health data solutions, marks a significant step in healthcare innovation and accessibility. This acquisition will complement previous acquisitions including InnovationsHR. This move aligns with our strategy to diversify our portfolio and bolster our healthcare sector presence.”
Kevin Longoria, CEO of RPM-One, also conveyed positive expectations when stating, “merging with Xalles Holdings will expedite our goal of implementing data technologies to address pressing issues, starting with healthcare accessibility through EZ Digital. Xalles’ RISE model is well-suited to support our growth and market penetration objectives.”
EZ Digital, powered by RPM-One’s Unified Telemetry Platform, utilizes proprietary AI for continuous health monitoring and patient engagement, prioritizing early detection and care, and offering unlimited access to licensed healthcare professionals across the U.S. Its scalability and financial model are in line with Xalles Holdings’ objective of employing technology to enhance services in various industries. This scheduled acquisition reflects both companies’ dedication to fostering growth, innovation, and delivering superior value to stakeholders.
The Share Exchange Agreement executed between Xalles Holdings and RPM-One allows time for a due diligence review to be completed before the planned transaction completion date of on or before January 31, 2024, at which time RPM-One will become a wholly owned subsidiary.
About Xalles Holdings Inc. (OTC: XALL)
Xalles Holdings Inc. is a leading holding company, specializing in innovative technology and financial service solutions. Focused on growth and diversification, Xalles Holdings is committed to developing cutting-edge technology-based solutions across various sectors, with an emphasis on supporting disruptive companies. Utilizing its proprietary Xalles RISE Business Model, the company actively seeks acquisition targets with solid management teams, robust business models, expansive total attainable markets (TAM), and enticing exit opportunities. Emphasizing the integration of blockchain and cutting-edge technologies, Xalles provides industry-leading solutions, poised to capture recurring revenue streams over time. Discover more at Xalles.com.
About RPM-One
RPM-One, Inc., a venture-backed leader in software and technology, revolutionizes systemic disparity solutions with its Unified Telemetry Platform (UTP), integrating data from diverse sources to provide actionable intelligence and clinical decision support. This fully managed solution, encompassing medical devices and an interoperable data analytics platform, caters to medically underserved populations within a value-based model, aligning stakeholder interests. RPM-One's flagship product, EZ Digital, streamlines digital healthcare for large organizations, while its commitment to innovation, reliability, support, and proven results reduces ownership costs and accelerates commercialization, making it a trusted partner for businesses focused on growth. For more information, visit www.rpm-one.com.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at SEC.gov and in OTC Markets at OTCMarkets.com.
Investor Relations Contact:
IR@xalles.com
IR: 202.779.1460